VYOME HOLDINGS, INC. Current State and Local Tax Expense (Benefit)
VYOME HOLDINGS, INC. (HIND) reported Current State and Local Tax Expense (Benefit) of $20.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2025-04-04
- VYOME HOLDINGS, INC. current state and local tax expense (benefit) for fiscal 2024 was $20.00K, a 185.71% increase from fiscal 2023.
- VYOME HOLDINGS, INC. current state and local tax expense (benefit) for fiscal 2023 was $7.00K, a 22.22% decline from fiscal 2022.
- VYOME HOLDINGS, INC. current state and local tax expense (benefit) for fiscal 2022 was $9.00K, a 18.18% decline from fiscal 2021.
- VYOME HOLDINGS, INC. current state and local tax expense (benefit) for fiscal 2021 was $11.00K, a 1000.00% increase from fiscal 2020.
| Period end | Current State and Local Tax Expense (Benefit) 12 month | Current State and Local Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2024-12-31 | $20.00K 10-K · filed 2025-04-04 | |
| 2023-12-31 | $7.00K 10-K · filed 2025-04-04 | |
| 2022-12-31 | $9.00K 10-K · filed 2024-04-01 | |
| 2021-12-31 | $11.00K 10-K · filed 2023-04-17 | |
| 2020-12-31 | $1.00K 10-K · filed 2022-04-08 | $0.00 10-K · filed 2021-03-12 |
| 2019-12-31 | $14.00K 10-K · filed 2021-03-12 | |
| 2018-12-31 | $11.00K 10-K · filed 2020-02-27 | |
| 2017-12-31 | $10.00K 10-K · filed 2019-02-22 | |
| 2016-12-31 | $2.00K 10-K · filed 2018-03-05 | |
| 2015-12-31 | $2.00K 10-K · filed 2018-03-05 | |
| 2014-12-31 | $2.00K 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |